https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/neurocognitive

The Latest

Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors Img

Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors

This will likely become the landmark study about the overall rate of neuropsychiatric side effects with this class of medicines over the next several years.

This Week in HIV Research: HIV Is Not an Obstacle

April 11, 2019: acute syphilis and virologic control; neuropsychological performance after switching off efavirenz; structural LGBTQ stigma and HIV criminalization in U.S. states; lung cancer resection surgery in people with HIV.

Depression Linked to Cognitive Dysfunction in HIV-Positive Women Img

Depression Linked to Cognitive Dysfunction in HIV-Positive Women

More research is needed to understand the connections between HIV, mental health, and the neurocircuitry that controls executive function.

This Week in HIV Research: The Clinical Impacts of HIV Stigma

Internalized HIV stigma, depression, and adherence in women; what “internalized HIV stigma” actually means; tenofovir-containing gel and genital herpes prevention; the neurocognitive effects of cerebrospinal HIV escape.

Doctor looking at brain scan

Six Things Providers Should Know About HIV-Associated Neurocognitive Disorders

HIV-associated neurocognitive disorders, including dementia, may be well-documented issues, but they're still being understood. New research answers some questions providers may have about HIV's impact on the brain.

Dual Maintenance Therapy With Dolutegravir + Rilpivirine Img

Dual Maintenance Therapy With Dolutegravir + Rilpivirine

In clinical trials called Sword 1 and Sword 2, researchers testing a combination of dolutegravir/rilpivirine (Juluca) found it to be effective and tolerable.

This Week in HIV Research: This Is Your Brain on Stigma

The impact of stigma on cognitive performance; risk factor dissonance among young black MSM; pregnancy and the HIV care continuum; new data on pediatric raltegravir use.

This Week in HIV Research: The PrEP Sex/Race Gap

PrEP access appears far from equal in the U.S.; HIV treatment and viral suppression disparities in Europe; how today’s hepatitis C treatments affect mortality; sex-based differences in cognitive impairment.

Man holdin his head

Lessons for Infectious Disease Doctors: Treating HIV, Pain, and Mental Illness

A staggering 60% of patients with HIV experience chronic pain compared with only 11% of the general population, according to Robert Bruce, M.D., M.A., M.Sc., who presented the latest research on pain and HIV at IDWeek 2018.

Eric Daar, M.D., and Claudia S. Crowell, M.D., M.P.H.

Neurological Conditions More Likely Among Children Exposed to Efavirenz in Utero

Efavirenz (Sustiva, Stocrin) use was associated with a 60% increased risk of neurological conditions in children, according to data presented at IDWeek 2018 in San Francisco.